Prostate | CancerDigest

Prostate Cancer

Niraparib nearly doubles progression-free survival in prostate cancer with specific genetic mutations

Men with prostate cancer whose tumors have specific genetic mutations saw a nearly 50 percent reduction in the risk of cancer progression when they received naraparib.

Michael O'Leary

Slightly higher dose radiation therapy over fewer weeks just as effective as standard regimen for early stage prostate cancer

Prostate cancer patients who received shorter, higher-dose course radiation treatment (MHFRT) had the same cancer control rates as those...

Michael O'Leary

Advanced imaging detects prostate cancer spread better than x-rays or CT-scans

Man undergoing PSMA-PET scan – image credit UCLA Health CANCER DIGEST – Jan. 5, 2025 – Nearly half of high-risk prostate cancer patients...

Michael O'Leary